可疑高同型半胱氨酸血症引起的门静脉系统血栓一例并文献复习
A Case of Portal System Thrombosis Caused by Suspected Hyperhomocysteine and Literature Review
DOI: 10.12677/ACM.2020.101009, PDF,   
作者: 丁红杰*：河津市人民医院介入科，山西 运城；刘 俊, 胡艾芳, 郭丽莹：河津市人民医院内分泌消化科，山西 运城；刘玉娥, 申 景：山西省人民医院介入科，山西 太原
关键词: 门静脉血栓；介入治疗；病因；Portal System Thrombosis； Interventional Therapy； Etiology
摘要: 目的：探讨门静脉系统血栓形成的病因及介入治疗对高同型半胱氨酸血症引起门静脉血栓的疗效。方法：回顾分析河津市人民医院介入科治疗收治的1例可疑高同型半胱氨酸血症引起的门静脉系统血栓，并检索国内外相关文献。结果：高同型半胱氨酸是引起门静脉系统血栓的一个重要因素，本例可疑高同型半胱氨酸血症引起的门静脉血栓，通过经肠系膜上动脉置管间接行门静脉系统溶栓，针对病因及伴随肠梗阻症状的治疗，血栓溶解，患者恢复良好。结论：对于可疑高同型半胱氨酸血症所引起的门静脉血栓采用经肠系膜上动脉置管间接门静脉溶栓安全、有效；有明确病因的患者，针对病因的治疗也不容忽视；对于合并肠梗阻的患者，禁饮食、胃肠减压等辅助治疗同样重要。
Abstract: Objective: To investigate the etiology of portal system thrombosis (PST) and the therapeutic effect of interventional therapy on PST caused by hyperhomocysteine. Methods: A case of PST caused by suspected hyperhomocysteine in Hejin People’s Hospital was retrospectively analyzed, and search the relevant literature at home and abroad. Result: Homocysteine is an important factor in PST, in this case of PST caused by suspected hyperhomocysteine, portal vein thrombolysis was performed indirectly through superior mesenteric artery catheterization, treatment for etiology and associated symptoms of intestinal obstruction, the PST dissolved and the patient recovered well. Conclusion: Indirect thrombolysis via superior mesenteric artery is safe and effective for PST caused by suspected hyperhomocysteine. For PST patient with clear pathogeny, the treatment that aims at pathogeny nots allow to ignore. For PST patients with intestinal obstruction, dietary restriction, gastrointestinal decompression and other adjuvant therapy are equally important.
文章引用：丁红杰, 刘俊, 胡艾芳, 郭丽莹, 刘玉娥, 申景. 可疑高同型半胱氨酸血症引起的门静脉系统血栓一例并文献复习[J]. 临床医学进展, 2020, 10(1): 51-55. https://doi.org/10.12677/ACM.2020.101009

参考文献

[1] 羊媛苑, 王晓燕. 门静脉系统血栓的发生发展机制[J]. 临床肝胆病杂志, 2018, 34(10): 2063-2068.
[2] Ogren, M., Bergqvist, D., Björck, M., et al. (2006) Portal Vein Thrombosis: Prevalence, Patient Characteristics and Lifetime Risk: A Population Study Based on 23,796 Consecutive Autopsies. World Journal of Gastroenterology, 12, 2115-2119.
[Google Scholar] [CrossRef] [PubMed]
[3] Harnik, I.G. and Brandt, L.J. (2010) Mesenteric Venous Thrombosis. Vascular Medicine, 15, 407-418.
[Google Scholar] [CrossRef] 
[4] Shah, S.R., Deshmukh, H.L. and Mathur, S.K. (2003) Extensive Portal and Splenic Vein Thrombosis: Differences in Hemodvnamics and Management. Hepatogastroenterology, 50, 1085-1089.
[5] Sobhonslidsuk, A. and Reddy, K.R. (2002) Portal Vein Thrombosis: A Concise Review. American Journal of Gastroenterology, 97, 535-541.
[Google Scholar] [CrossRef] [PubMed]
[6] Denninger, M.H., Chaït, Y., Casadevall, N., et al. (2000) Cause of Portal or Hepatic Venous Thrombosis in Adults: The Role of Multiple Concurrent Factors. Hepatology, 31, 587-591.
[Google Scholar] [CrossRef] [PubMed]
[7] Plessier, A., Darwish-Murad, S., Hernandez-Guerra, M., et al. (2010) European Network for Vascular Disorders of the Liver (EN-Vie). Acute Portal Vein Thrombosis Unrelated to Cirrhosis: A Prospective Multicenter Follow-Up Study. Hepatology, 51, 210-218.
[Google Scholar] [CrossRef] [PubMed]
[8] Poplausky, M.R., Kaufman, J.A., Geller, S.C., et al. (1996) Mesenteric Venous Thrombosis Treated with Urokinase via the Superior Mesenteric Artery. Gastroenterology, 110, 1633-1635.
[Google Scholar] [CrossRef] [PubMed]
[9] Rivitz, S.M., Geller, S.C., Hahn, C., et al. (1995) Treatment of Acute Mesenteric Venous Thrombosis with Transjugular Intramesenteric Urokinase Infusion. Journal of Vascular and Interventional Radiology, 6, 219-228.
[Google Scholar] [CrossRef] 
[10] Sehgal, M. and Haskal, Z.J. (2000) Use of Transjugular Intrahepatic Porto Systemic Shunts during Lytic Therapy of Extensive Portal Splenic and Mesenteric Venous Thrombosis : Long-Term Follow-Up. Journal of Vascular and Interventional Radiology, 11, 61-65.
[11] 王茂强, 王志强, 刘迎娣, 等. 门静脉和肠系膜上静脉血栓形成的介入治疗[J]. 中华普通外科杂志, 2004, l9(9): 540-542.
[12] 段鹏飞, 李晓强, 钱爱民, 等. 急性肠系膜上静脉血栓形成的手术及介入治疗[J]. 中华普通外科杂志, 2013, 28(7): 504-506.

为你推荐